Lower urinary tract symptoms associated with benign prostatic hyperplasia: combined treatment with fesoterodine fumarate extended-release and tamsulosin--a prospective study.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To evaluate the efficacy and safety of fesoterodine extended-release (ER) plus tamsulosin in men with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Urol Int

Title: Urologia internationalis

Publisher: S. Karger AG

ISSN (Electronic): 1423-0399

ISSN (Print): 0042-1138

Publication date (Electronic): 2013

Volume: 90

Issue: 2

Affiliations

[1 ] Department of Urology, National Institute of Rehabilitation, Athens, Greece.

Article

Publisher Item ID: 000345050

DOI: 10.1159/000345050

PubMed ID: 23221480

SO-VID: e9cc7d8e-c8b8-4a00-b6be-eb19a994be07

History

Data availability:

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Cited by 2

See all cited by